DDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract Cancer

NCT04298021 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Bile Duct Cancer
Chemotherapy Effect

Interventions

DRUG: AZD6738
DRUG: Durvalumab
DRUG: Olaparib

Sponsor

Seoul National University Hospital